| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0077 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |